Anne Chew

17.1k citations

34 papers · 9.6k indexed · 4 hit papers · h-index 19

Impact in

Oncology top 0.1%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Immunology top 0.5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in

Oncology 25
- CAR-T cell therapy research 24
Genetics 8
- Chronic Lymphocytic Leukemia Research 8
- Virus-based gene therapy research 7

Co-authors: Carl H. June Bruce L. Levine Stephan A. Grupp David L. Porter David M. Barrett David T. Teachey Richard Aplenc Susan R. Rheingold
Journals: Blood (13 papers)Journal of Clinical Oncology (4 papers)Molecular Therapy (2 papers)New England Journal of Medicine (2 papers)Genomics (2 papers)
Partner nations: United States Switzerland

In The Last Decade

Anne Chew

32 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia 2015 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Science Translational Medicine
2014 New England Journal of Medicine
2013 New England Journal of Medicine
2013 Cancer Immunology Research

Peers

Countries citing papers authored by Anne Chew

Since Specialization

Citations

This map shows the geographic impact of Anne Chew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Chew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Chew more than expected).

Fields of papers citing papers by Anne Chew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Chew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Chew. The network helps show where Anne Chew may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Chew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Chew Line = papers co-authored together Anne Chew links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-term stability of clinical-grade lentiviral vectors for cell therapy Molecular Therapy — Methods & Clinical Development ·Julie K. Jadlowsky, Rachel Leskowitz, S.J. McKenna, Jayashree Karar, Yujie Ma, Anlan Dai, Gabriela Plesa, Fang Chen, Kathleen A. Alexander, Jennifer Petrella, Nan Gong, Wei‐Ting Hwang, Olivia Farrelly, Julie S. Barber-Rotenberg, Shannon Christensen, Vanessa Gonzalez, Anne Chew, Joseph A. Fraietta, Carl H. June	2024	7
2	671 Phase 1 trial of human chimeric antigen receptor modified T cells (huCART-meso) administered in combination with oncolytic virus VCN-01 in patients with pancreatic and ovarian cancer SHILAP Revista de lepidopterología ·János L. Tanyi, Mark H. O’Hara, Elizabeth O. Hexner, Amy Marshall, Julie K. Jadlowsky, Matthew Ferrara, Olivia Farrelly, Adam Runkle, Anne Chew, Emily Dowd, Vanessa Gonzalez, Joseph A. Fraietta, Gabriela Plesa, Neil C. Sheppard, Carl H. June	2023	0
3	Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors Cell Reports Medicine ·In-Young Jung, Estela Noguera-Ortega, Robert L. Bartoszek, Sierra M. Collins, Erik F. Williams, Megan M. Davis, Julie K. Jadlowsky, Gabriela Plesa, Donald L. Siegel, Anne Chew, Bruce L. Levine, Shelley L. Berger, Edmund K. Moon, Steven Μ. Albelda, Joseph A. Fraietta	2023	36
4	Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products Molecular Therapy ·Kenneth Cornetta, Lisa Duffy, Cameron J. Turtle, Michael C. Jensen, Stephen J. Forman, Gwendolyn Binder-Scholl, Terry J. Fry, Anne Chew, David G. Maloney, Carl H. June	2017	64
5	Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients Molecular Therapy ·Katherine T. Marcucci, Julie K. Jadlowsky, Wei‐Ting Hwang, Megan Suhoski-Davis, Vanessa Gonzalez, Irina Kulikovskaya, Minnal Gupta, Simon F. Lacey, Gabriela Plesa, Anne Chew, J. Joseph Melenhorst, Bruce L. Levine, Carl H. June	2017	91
6	Randomized, phase II dose optimization study of chimeric antigen receptor (CAR) modified T cells directed against CD19 in patients (pts) with relapsed, refractory (R/R) CLL. Journal of Clinical Oncology ·David L. Porter, Norbert Frey, Jan J. Melenhorst, Wei‐Ting Hwang, Simon F. Lacey, Pamela A. Shaw, Anne Chew, Katherine T. Marcucci, Saar Gill, Alison W. Loren, Anthony R. Mato, Stephen J. Schuster, Lester Lledo, Holly McConville, Joan Gilmore, James Capobianchi, Michael Kalos, Stephan A. Grupp, Bruce L. Levine, Carl H. June	2016	28
7	Treatment with Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) Results in Durable Remissions in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphomas of Germinal Center and Non-Germinal Center Origin, "Double Hit" Diffuse Large B Cell Lymphomas, and Transformed Follicular to Diffuse Large B Cell Lymphomas Blood ·Stephen J. Schuster, Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Nicole Winchell, Daniel J. Landsburg, David L. Porter, Anthony R. Mato, Honore T. Strauser, April M. Schrank-Hacker, Mariusz A. Wasik, Simon F. Lacey, J. Joseph Melenhorst, Anne Chew, Jens Hasskarl, Katherine T. Marcucci, Bruce L. Levine, Carl H. June	2016	15
8	Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019) in Patients with Poor Prognosis, Relapsed or Refractory CD19+ Follicular Lymphoma: Prolonged Remissions Relative to Antecedent Therapy Blood ·Elise A. Chong, Jakub Svoboda, Sunita D. Nasta, David Porter, Nicole Winchell, Daniel J. Landsburg, Anthony R. Mato, Simon F. Lacey, J. Joseph Melenhorst, Anne Chew, Jens Hasskarl, Katherine T. Marcucci, Bruce L. Levine, Carl H. June, Stephen J. Schuster	2016	18
9	Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia New England Journal of Medicine ·Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, Richard Aplenc, David M. Barrett, Nancy Bunin, Anne Chew, Vanessa Gonzalez, Zhaohui Zheng, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Susan R. Rheingold, Angela Shen, David T. Teachey, Bruce L. Levine, Carl H. June, David L. Porter, Stephan A. Grupp Hit paper breakdown →	2014	3933
10	Cytokine Release Syndrome (CRS) after Chimeric Antigen Receptor (CAR) T Cell Therapy for Relapsed/Refractory (R/R) CLL Blood ·David L. Porter, Simon F. Lacey, Wei‐Ting Hwang, Pamela A. Shaw, Noelle V. Frey, Anne Chew, Fang Chen, Michael Kalos, Vanessa Gonzalez, Katherine T. Marcucci, Shannon L. Maude, J. Joseph Melenhorst, Manuel Litchman, David T. Teachey, Angela Shen, Alfonso Quintas-Cardamas, Patricia A. Wood, Bruce L. Levine, Carl H. June, Stephan A. Grupp	2014	6
11	Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies Cancer Immunology Research ·Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus, Drew A. Torigian, Michael C. Soulen, Gabriela Plesa, Anne Chew, Yangbing Zhao, Bruce L. Levine, Steven Μ. Albelda, Michael Kalos, Carl H. June Hit paper breakdown →	2013	693
12	Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia New England Journal of Medicine ·Stephan A. Grupp, Michael Kalos, David M. Barrett, Richard Aplenc, David L. Porter, Susan R. Rheingold, David T. Teachey, Anne Chew, Bernd Hauck, J. Fraser Wright, Michael C. Milone, Bruce L. Levine, Carl H. June Hit paper breakdown →	2013	2631
13	Chimeric Antigen Receptor Modified T Cells Directed Against CD19 (CTL019 cells) Have Long-Term Persistence and Induce Durable Responses In Relapsed, Refractory CLL Blood ·David L. Porter, Michael Kalos, Norbert Frey, Stephan A. Grupp, Alison W. Loren, Christina Jemison, Joan Gilmore, Holly McConville, James Capobianchi, Lester Lledo, Anne Chew, Zhaohui Zheng, Bruce L. Levine, Carl H. June	2013	22
14	Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research ·Yangbing Zhao, Edmund K. Moon, Carmine Carpenito, Chrystal M. Paulos, Xiaojun Liu, Andrea Brennan, Anne Chew, Richard G. Carroll, John Scholler, Bruce L. Levine, Steven Μ. Albelda, Carl H. June	2010	366
15	Transfer of influenza vaccine–primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial Blood ·Edward A. Stadtmauer, Dan T. Vogl, Eline T. Luning Prak, Jean Boyer, Nicole A. Aqui, Aaron P. Rapoport, Kenyetta R. McDonald, Xiaoling Hou, Heather Murphy, Rita Bhagat, Patricia Mangan, Anne Chew, Elizabeth Veloso, Bruce L. Levine, Robert H. Vonderheide, Abbas F. Jawad, Carl H. June, Kathleen E. Sullivan	2010	27
16	Functional and Genomic Analysis of the Human Mitochondrial Intermediate Peptidase, a Putative Protein Partner of Frataxin Genomics ·Anne Chew, Giorgio Sirugo, John P. Alsobrook, Grazia Isaya	2000	20
17	Cloning, Expression, and Chromosomal Assignment of the Human Mitochondrial Intermediate Peptidase Gene (MIPEP) Genomics ·Anne Chew, Elizabeth Buck, Shani Peretz, Giorgio Sirugo, Piero Rinaldo, Grazia Isaya	1997	26
18	Mutations in a Putative Zinc-Binding Domain Inactivate the Mitochondrial Intermediate Peptidase Biochemical and Biophysical Research Communications ·Anne Chew, Robert A. Rollins, Wayne Sakati, Grazia Isaya	1996	12
19	Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice. The Journal of Experimental Medicine ·Catherine J. Painter, Marc Monestier, Anne Chew, A Bona-Dimitriu, Kuppuswamy N. Kasturi, Charles Bailey, V E Scott, C L Sidman, Constantin A. Bona	1988	62
20	Cyclophosphamide in the treatment of systemic lupus erythematosus. BMJ ·C. Siang, Seah, Kimberly Wong, Anne Chew, F. J. Jayaratnam	1966	28

About Anne Chew

Anne Chew is a scholar working on Oncology, Genetics, Immunology, Pathology and Forensic Medicine and Genetics, having authored 34 papers that have together received 9.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (24 papers), Chronic Lymphocytic Leukemia Research (8 papers), Virus-based gene therapy research (7 papers), Acute Lymphoblastic Leukemia research (5 papers), Immune Cell Function and Interaction (5 papers), Lymphoma Diagnosis and Treatment (5 papers), T-cell and B-cell Immunology (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). The work is most often cited by research in Oncology (8.4k citations), Immunology (3.3k citations), Genetics (2.6k citations), Hematology (708 citations) and Biomedical Engineering (2.3k citations). Anne Chew has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Carl H. June, Bruce L. Levine, Stephan A. Grupp, David L. Porter, David M. Barrett, David T. Teachey, Richard Aplenc, Susan R. Rheingold, Simon F. Lacey and J. Joseph Melenhorst. Their work appears in journals such as Blood, Journal of Clinical Oncology, Molecular Therapy, New England Journal of Medicine and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact